CAMP STIMULATED SWEAT RATE IN CYSTIC FIBROSIS

囊性纤维化中 CAMP 刺激出汗率

基本信息

  • 批准号:
    7604524
  • 负责人:
  • 金额:
    $ 0.04万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-12-01 至 2007-09-16
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of this project is the development of a cyclic-AMP(cAMP)-stimulated "sweat rate" test that will discriminate between fully functional, partially functional, and non-functional forms of the Cystic Fibrosis Transmembrane Conductance Regulator(CFTR). Sweat production can be stimulated by both cholinergic & adrenergic agonists. Collection of cholinergic stimulated sweat & the subsequent measurement of sweat chloride concentration is the basis of a standard diagnostic test for cystic fibrosis (CF), the pilocarpine iontophoresis sweat test. Stimulation of sweat production with pilocarpine leads to initial production of an isotonic secretion in the sweat gland. In non-CF patients, as the secretion traverses the sweat duct, chloride is reabsorbed leading to low concentrations of chloride in sweat as it appears on the skin. This chloride resorption is dependent on the presence of functional CFTR. In CF patients, who lack functional CFTR, the sweat chloride concentration remains high, & distinguishes most, but not all, CF from non-CF patients. However, this technique does not distinguish heterozygote carriers of CFTR mutations from non-carriers, nor does the sweat chloride concentration correlate with disease severity. The hypothesis is that measurement of cAMP-mediated sweat rates will distinguish among CF subjects, non-CF subjects, and non-affected carriers of CFTR mutations. A secondary hypothesis is that there will be a correlation between CFTR activity and sweat rate such that non-affected carriers of CFTR mutations will have intermediate sweat rates to CF and non-CF control subjects. Another secondary hypothesis is that different classes of CFTR mutations can be associated with different levels of sweat rate. Subjects of both genders and all ages are eligible for entry.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pamela L. Zeitlin其他文献

Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure emin vitro/em
  • DOI:
    10.1016/j.jcf.2022.02.011
  • 发表时间:
    2022-07-01
  • 期刊:
  • 影响因子:
    6.000
  • 作者:
    Ciaran A. Shaughnessy;Pamela L. Zeitlin;Preston E. Bratcher
  • 通讯作者:
    Preston E. Bratcher
The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists.
囊性纤维化的变化:麻醉师的更新。
  • DOI:
    10.1213/ane.0000000000005856
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    5.7
  • 作者:
    Amy J. Lee;J. Huffmyer;Eryn L Thiele;Pamela L. Zeitlin;D. Chatterjee
  • 通讯作者:
    D. Chatterjee
717. VCP Short Hairpin RNA Rescues ΔF508- CFTR and Suppresses IL8 Levels: Therapeutic Implications in Cystic Fibrosis
  • DOI:
    10.1016/j.ymthe.2006.08.796
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Neeraj Vij;Shengyun Fang;Pamela L. Zeitlin
  • 通讯作者:
    Pamela L. Zeitlin

Pamela L. Zeitlin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pamela L. Zeitlin', 18)}}的其他基金

Mechanism of Prostone Activation During CFTR Modulation
CFTR 调节过程中前列酮激活的机制
  • 批准号:
    10687435
  • 财政年份:
    2022
  • 资助金额:
    $ 0.04万
  • 项目类别:
Ph 1-2 Study of Glycerolphenylbutyrate for Cystic Fibrosis IND 125,124 (12/5/15)
Ph 1-2 甘油苯基丁酸酯治疗囊性纤维化的研究 IND 125,124 (12/5/15)
  • 批准号:
    9322858
  • 财政年份:
    2016
  • 资助金额:
    $ 0.04万
  • 项目类别:
Chloride Channels in Lung Development
肺部发育中的氯离子通道
  • 批准号:
    7824125
  • 财政年份:
    2009
  • 资助金额:
    $ 0.04万
  • 项目类别:
Phase 2 study of digitoxin for cystic fibrosis - IND 70279
洋地黄毒苷治疗囊性纤维化的 2 期研究 - IND 70279
  • 批准号:
    7566224
  • 财政年份:
    2008
  • 资助金额:
    $ 0.04万
  • 项目类别:
Phase 2 study of digitoxin for cystic fibrosis - IND 70279
洋地黄毒苷治疗囊性纤维化的 2 期研究 - IND 70279
  • 批准号:
    7689355
  • 财政年份:
    2008
  • 资助金额:
    $ 0.04万
  • 项目类别:
Phase 2 study of digitoxin for cystic fibrosis - IND 70279
洋地黄毒苷治疗囊性纤维化的 2 期研究 - IND 70279
  • 批准号:
    8238123
  • 财政年份:
    2008
  • 资助金额:
    $ 0.04万
  • 项目类别:
Phase 2 Study of Digitoxin for the Treatment of Cystic Fibrosis
洋地黄毒素治疗囊性纤维化的 2 期研究
  • 批准号:
    8747904
  • 财政年份:
    2007
  • 资助金额:
    $ 0.04万
  • 项目类别:
TRANSEPITHELIAL POTENTIAL DIFFERENCE IN PTS W/ VARIANTS OF CYSTIC FIBROSIS (CF)
囊性纤维化 (CF) 变体 PTS 的跨上皮电位差
  • 批准号:
    7604525
  • 财政年份:
    2006
  • 资助金额:
    $ 0.04万
  • 项目类别:
ASSESSMENT OF INDUCED SPUTUM
诱发痰的评估
  • 批准号:
    7604596
  • 财政年份:
    2006
  • 资助金额:
    $ 0.04万
  • 项目类别:
A PHASE 2 STUDY OF PTC124 FOR CYSTIC FIBROSIS
PTC124 治疗囊性纤维化的 2 期研究
  • 批准号:
    7604667
  • 财政年份:
    2006
  • 资助金额:
    $ 0.04万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 0.04万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 0.04万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 0.04万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 0.04万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 0.04万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 0.04万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了